Neurorestorative treatments of stroke increase synaptic plasticity in the ischemic boundary zone [45], [46], as evidenced by increased expression of synaptic proteins such as synaptophysin and growth-associated protein 43 [47]. The gene discussed is SYP; the disease is stroke disorder.